Jazz Pharmaceuticals
Clinical trials sponsored by Jazz Pharmaceuticals, explained in plain language.
A biopharmaceutical company focused on neuroscience and oncology treatments.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New hope for advanced stomach cancer: experimental combo targets HER2-positive tumors Results expected Sep 2026 (estimated)
- New antibody drug targets HER2 cancers in broad trial Results expected Dec 2026 (estimated)
- CBD epilepsy drug under Real-World watch for rare seizure disorders Results expected Feb 2027 (estimated)
- First human test of JZP269: can this experimental drug pass the safety check? Results expected Feb 2027 (estimated)
- Epidiolex liver check: is Long-Term use safe? Results expected Aug 2027 (estimated)
-
New narcolepsy drug tested in tiny trial – but study halted early
Symptom relief Stopped earlyThis early-stage trial tested an experimental drug called JZP441 in just 6 adults with narcolepsy type 1, a condition that causes sudden daytime sleepiness. The goal was to see if the drug could help people stay awake longer, as measured by a standard sleep test. However, the stu…
Phase 1 • Sponsor: Jazz Pharmaceuticals • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
CBD study for baby seizures halted early
Symptom relief Stopped earlyThis study tested a cannabidiol (CBD) oral solution in children under 2 years old with tuberous sclerosis complex, Dravet syndrome, or Lennox-Gastaut syndrome who had uncontrolled seizures. The goal was to see if CBD is safe and can reduce seizures. However, the study was termina…
Phase 3 • Sponsor: Jazz Pharmaceuticals • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC